IP Library Granted Patent US 7,955,294
Granted Patent B2
US 7,955,294 · App. 11/598,221 · Granted Jun 7, 2011

Intermittent dosing of nitric oxide gas

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,955,294
App. No.
11/598,221
Granted
Jun 7, 2011
Kind
B2
Abstract

A method and corresponding device are described for combating microbes and infections by delivering intermittent high doses of nitric oxide to a mammal for a period of time and which cycles between high and low concentration of nitric oxide gas. The high concentration of nitric oxide is preferably delivered intermittently for brief periods of time that are interspersed with periods of time with either no nitric oxide delivery or lower concentrations of nitric oxide. The method is advantageous because at higher concentration, nitric oxide gas overwhelms the defense mechanism of pathogens that use the mammalian body to replenish their thiol defense system. A lower dose or concentration of nitric oxide gas delivered in between the bursts of high concentration nitric oxide maintains nitrosative stress pressure on the pathogens and also reduces the risk of toxicity of nitric oxide gas.

Claims (34)

1. A method of topically delivering nitric oxide gas to a mammal to kill or inhibit the growth of microbes, the method comprising alternately administering at least a first concentration of nitric oxide gas and a second concentration of nitric oxide gas for a number of cycles, the first concentration applied topically for a first period of time sufficient to overwhelm the microbes' thiol defense mechanisms and kill or inhibit the growth of at least a portion of the microbes, and the second concentration lower than the first concentration and applied topically for a second period of time sufficient to maintain nitrosative stress on the microbes and interfere with replenishing the level of the microbes' thiol defense mechanisms, whereby the cycling of the first and second concentrations provides a cumulative killing of the microbes.

2. The method of claim 1 wherein the second period of time is longer than the first period of time.

3. The method of claim 1 wherein the first concentration of nitric oxide gas ranges from about 160 ppm to about 400 ppm.

4. The method of claim 3 wherein the second concentration of nitric oxide gas is less than about 80 ppm.

5. The method of claim 2 wherein the first period of time is about 30 minutes and the second period of time is about 3.5 hours.

6. A method of topically delivering nitric oxide gas to a mammal to kill or inhibit the growth of microbes, the method comprising topically administering to the mammal a first concentration of nitric oxide gas for a number of time periods that are interspersed with intervals in between wherein a second concentration of nitric oxide gas lower than the first concentration is topically administered during the intervals, wherein the first concentration of nitric oxide gas is sufficient to overwhelm the microbes' thiol defense mechanisms and kill or inhibit the growth of at least a portion of the microbes and the second concentration of nitric oxide gas is sufficient to maintain nitrosative stress on the microbes and interfere with replenishing the level of the microbes' thiol defense mechanisms, and whereby the topical administration of the first concentration and second concentration for a number of cycles provides a cumulative killing of the microbes.

7. The method of claim 6 wherein the first concentration of nitric oxide gas ranges from about 160 ppm to about 400 ppm.

8. The method of claim 7 wherein the second concentration of nitric oxide gas is less than about 80 ppm.

9. The method of claim 6 wherein the microbes are selected from a group consisting of bacteria, mycobacteria, viruses and fungi.

10. A device for delivery of nitric oxide gas to kill or inhibit the growth of microbes comprising:

a source of nitric oxide gas;

a source of diluent gas;

a delivery interface adaptable for topical delivery of the gases to a mammal;

a gas mixer downstream of the sources of nitric oxide gas and diluent gas and upstream of the delivery interface for mixing the nitric oxide gas with the diluent gas;

a controller that communicates with the gas mixer wherein the controller comprises logic for setting a nitric oxide gas delivery profile comprising at least a first concentration of nitric oxide gas sufficient to overwhelm the microbes' thiol defense mechanisms and kill or inhibit the growth of at least a portion of the microbes and a second concentration of nitric oxide gas sufficient to maintain nitrosative stress on the microbes and interfere with replenishing the level of the microbes' thiol defense mechanisms, and for automatically switching between the at least first and second concentrations of nitric oxide gas on a timed basis for a number of cycles, whereby the cycling of the first and second concentrations provides a cumulative killing of the microbes.

11. The device of claim 10 wherein each cycle comprises at least first and second time periods corresponding respectively to delivery of the first and second concentrations of nitric oxide gas.

12. The device of claim 11 wherein, in each cycle, the first time period is shorter than the second time period.

13. The device of claim 10 wherein the gas mixer comprises a T or Y shaped tubing connection and a flow control valve.

14. The device of claim 10 wherein the gas mixer comprises a gas blender.

15. The device of claim 10 wherein the delivery interface comprises a bathing unit for topical delivery of nitric oxide gas to a surface of the body.

16. The device of claim 10 further comprising a nitric oxide gas analyzer for measuring the concentration of nitric oxide gas flowing to the delivery interface, wherein the nitric oxide gas analyzer sends signals to the controller.

17. A device for delivery of nitric oxide gas to kill or inhibit the growth of microbes comprising:

a first source of gas;

a second source of gas;

a delivery interface adaptable for topical delivery of the gases to a mammal;

a switch valve downstream of the first and second sources of gas and upstream of the delivery interface, said switch valve for directing the flow of the gases from their sources to the delivery interface; and

a controller controlling the switch valve and which commands the switch valve to switch between the first and second sources of gas on a timed basis for a number of cycles;

wherein the first source of gas has a higher concentration of nitric oxide gas than the second source of gas and the controller causes the gases to be administered according to a delivery profile that provides sufficient nitric oxide gas to affect a cumulative killing of microbes;

wherein the concentration of nitric oxide gas in the first source of gas is sufficient to overwhelm the microbes' thiol defense mechanisms and to kill or inhibit the growth of at least a portion of the microbes and the concentration of nitric oxide gas in the second source of gas is sufficient to maintain nitrosative stress on the microbes and interfere with replenishing the level of the microbes' thiol defense mechanisms; and

wherein cycling between the first and second sources of gas provides a cumulative killing of the microbes.

18. The device of claim 17 wherein each cycle comprises at least first and second time periods corresponding respectively to delivery of the first and second gases.

19. The device of claim 18 wherein, in each cycle, the first time period is shorter than the second time period.

20. The device of claim 17 wherein the delivery interface comprises a bathing unit for topical delivery of the gases to a surface of the body.

21. The device of claim 17 further comprising a nitric oxide gas analyzer for measuring the concentration of nitric oxide gas flowing to the delivery interface, wherein the nitric oxide gas analyzer sends signals to the controller.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Dec 13, 2024
From: VYAIRE MEDICAL, INC., ET AL.'S CREDITORS
To: ZOLL MEDICAL CORPORATION
Reel/Frame 069635/0201 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2024
From: SENSORMEDICS CORPORATION
To: ZOLL MEDICAL CORPORATION
Reel/Frame 069417/0037 →
CHANGE OF NAME Recorded Aug 12, 2022
From: ADVANCED INHALATION THERAPIES (AIT) LTD.
To: BEYOND AIR LTD
Reel/Frame 061164/0767 →
SECURITY INTEREST Recorded May 9, 2019
From: SENSORMEDICS CORPORATION
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 049126/0905 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2018
From: AIT THERAPEUTICS, INC.
To: ADVANCED INHALATION THERAPIES (AIT) LTD.
Reel/Frame 047562/0295 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2018
From: ADVANCED INHALATION THERAPIES (AIT) LTD.
To: AIT THERAPEUTICS, INC.
Reel/Frame 046234/0061 →
SECOND LIEN SECURITY AGREEMENT Recorded Apr 18, 2018
From: SENSORMEDICS CORPORATION
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 045782/0851 →
FIRST LIEN SECURITY AGREEMENT Recorded Apr 18, 2018
From: SENSORMEDICS CORPORATION
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 045968/0865 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2017
From: PULMONOX TECHNOLOGIES CORPORATION
To: ADVANCED INHALATION THERAPIES (AIT) LTD.
Reel/Frame 043779/0488 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2008
From: MILLER, CHRISTOPHER; MCMULLIN, BEVIN
To: PULMONOX TECHNOLOGIES CORPORATION
Reel/Frame 020578/0817 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2008
From: STENZLER, ALEX
To: SENSORMEDICS CORPORATION
Reel/Frame 020515/0814 →